BMC to seal buildings in north Mumbai’s slums and congested areas amid sharp rise in coronavirus cases
North Mumbai, which includes Dahisar, Borivali, Malad, Charkop and Kandivali areas, has seen a sharp rise in cases in the last 15 days.

Mumbai: Buildings in congested areas and slums of north Mumbai will be sealed considering the rise in COVID-19 cases in the last 15 days, Mumbai Police commissioner Param Bir Singh said.
During a visit to north Mumbai on Friday, the city top cop attributed the spread of coronavirus infection to the high population density here.
North Mumbai, which includes Dahisar, Borivali, Malad, Charkop and Kandivali areas, has seen a sharp rise in cases in the last 15 days.
Singh took stock of the COVID-19 count and precautionary measures taken by the police and Brihanmumbai Municipal Corporation (BMC) to contain the viral spread.
Several cases have been reported from buildings located in slums and other high-density places, he said, adding that the police were sealing such structures and the results of these measures will be seen in the next few days.
The city currently has 750 containment zones, of which 300 are located in north Mumbai alone, Singh said.
Apart from this, the police have identified 27 hotspots and a strict lockdown has been enforced in these areas, he said.
People should follow social distancing norms to break the chain of the spread and should wear masks, use sanitisers if they step out of their homes for any urgent work, Singh said.
According to the BMC's data, Mumbai has so far recorded 72,287 COVID-19 cases, while the toll stood at 4,177.
also read

On this day: Important events that happened on 11 March in the past
The World Health Organization (WHO) had declared on 11 March 2020 that the COVID-19 outbreak was a pandemic

This is why Beijing's population has declined for 1st time in 2 decades
Beijing's population decline was in line with national trends, with China's population falling last year for the first time in six decades

COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the final say on giving Pfizer's drug full approval and is expected to decide by May.